Search Results - "Bioulac, Bernard H."

Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia by Aubert, Incarnation, Guigoni, Céline, Håkansson, Kerstin, Li, Qin, Dovero, Sandra, Barthe, Nicole, Bioulac, Bernard H., Gross, Christian E., Fisone, Gilberto, Bloch, Bertrand, Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa therapy for Parkinson's disease. Although changes affecting D1 and D2…”
Get full text

RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease by Gold, Stephen J, Hoang, Chau V, Potts, Bryan W, Porras, Gregory, Pioli, Elsa, Kim, Ki Woo, Nadjar, Agnes, Qin, Chuan, LaHoste, Gerald J, Li, Qin, Bioulac, Bernard H, Waugh, Jeffrey L, Gurevich, Eugenia, Neve, Rachael L, Bezard, Erwan

“…Chronic L-dopa treatment of Parkinson's disease (PD) often leads to debilitating involuntary movements, termed L-dopa-induced dyskinesia (LID), mediated by…”
Get more information

Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease by Ahmed, Mohamed R, Berthet, Amandine, Bychkov, Evgeny, Porras, Gregory, Li, Qin, Bioulac, Bernard H, Carl, Yonatan T, Bloch, Bertrand, Kook, Seunghyi, Aubert, Incarnation, Dovero, Sandra, Doudnikoff, Evelyne, Gurevich, Vsevolod V, Gurevich, Eugenia V, Bezard, Erwan

“…Parkinson's disease is caused primarily by degeneration of brain dopaminergic neurons in the substantia nigra and the consequent deficit of dopamine in the…”
Get more information

Striatal Overexpression of ΔJunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease by Berton, Olivier, Guigoni, Céline, Li, Qin, Bioulac, Bernard H., Aubert, Incarnation, Gross, Christian E., DiLeone, Ralph J., Nestler, Eric J., Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of dopamine replacement therapy for Parkinson disease (PD). The transcription…”
Get full text

Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism by Dupuis, Julien Pierre, Feyder, Michael, Miguelez, Cristina, Garcia, Liliana, Morin, Stéphanie, Choquet, Daniel, Hosy, Eric, Bezard, Erwan, Fisone, Gilberto, Bioulac, Bernard H, Baufreton, Jérôme

“…Impairments of synaptic plasticity are a hallmark of several neurological disorders, including Parkinson's disease (PD) which results from the progressive loss…”
Get more information

Long-term depression at distinct glutamatergic synapses in the basal ganglia by Dupuis, Julien P., Bioulac, Bernard H., Baufreton, Jérôme

“…Long-term adaptations of synaptic transmission are believed to be the cellular basis of information storage in the brain. In particular, long-term depression…”
Get full text

Enhanced Preproenkephalin-B–Derived Opioid Transmission in Striatum and Subthalamic Nucleus Converges Upon Globus Pallidus Internalis in L-3,4-dihydroxyphenylalanine–Induced Dyskinesia by Aubert, Incarnation, Guigoni, Céline, Li, Qin, Dovero, Sandra, Bioulac, Bernard H., Gross, Christian E., Crossman, Alan R., Bloch, Bertrand, Bezard, Erwan

“…A role for enhanced opioid peptide transmission has been suggested in the genesis of levodopa-induced dyskinesia. However, basal ganglia nuclei other than the…”
Get full text

Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia by Guigoni, Céline, Li, Qin, Aubert, Incarnation, Dovero, Sandra, Bioulac, Bernard H, Bloch, Bertrand, Crossman, Alan R, Gross, Christian E, Bezard, Erwan

“…Dyskinesia represents a debilitating complication of L-3,4-dihydroxyphenylalanine (L-dopa) therapy for Parkinson's disease. Such motor manifestations are…”
Get more information

Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning by Guigoni, Céline, Dovero, Sandra, Aubert, Incarnation, Li, Qin, Bioulac, Bernard H., Bloch, Bertrand, Gurevich, Eugenia V., Gross, Christian E., Bezard, Erwan

“…The extent of nigrostriatal denervation is presumed to play a role in the genesis of levodopa‐induced dyskinesia. Yet some parkinsonian patients who have been…”
Get full text

Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors by Guigoni, C., Aubert, I., Li, Q., Gurevich, V.V., Benovic, J.L., Ferry, S., Mach, U., Stark, H., Leriche, L., Håkansson, K., Bioulac, Bernard H., Gross, Christian E., Sokoloff, Pierre, Fisone, Gilberto, Gurevich, E.V., Bloch, Bertrand, Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa therapy for Parkinson's disease. Taking advantage of a monkey brain…”
Get full text

Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease by Meissner, Wassilios, Guigoni, Celine, Cirilli, Laetitia, Garret, Maurice, Bioulac, Bernard H., Gross, Christian E., Bezard, Erwan, Benazzouz, Abdelhamid

“…The mechanisms of action of high‐frequency stimulation (HFS) of the subthalamic nucleus (STN) remain only partially understood. Hitherto, experimental studies…”
Get full text

Asymmetrically lesioned mesencephalon in healthy rodents: call for caution by Pioli, Elsa Y., Dovero, Sandra, Bioulac, Bernard H., Gross, Christian E., Bezard, Erwan

“…Stereological counting of tyrosine-hydroxylase immunoreactive (TH-IR) neurons in the mesencephalon is a pivotal parameter in assessing the extent of lesioning…”
Get full text

Partial bilateral mesencephalic lesions affect D1 but not D2 binding in both the striatum and cortex by Pioli, Elsa, Sohr, Reinhard, Meissner, Wassilios, Barthe, Nicole, Gross, Christian E., Bezard, Erwan, Bioulac, Bernard H.

“…The substantia nigra pars compacta (SNc) and the ventral tegmental area (VTA) are the two major mesencephalic dopaminergic systems. Mesencephalic dopamine…”
Get full text

The deafferented nonhuman primate is not a reliable model of intractable pain by Pioli, Elsa Y., Gross, Christian E., Meissner, Wassilios, Bioulac, Bernard H., Bezard, Erwan

“…Before extending the application of motor cortex stimulation it is important to investigate the intimate mechanisms by which it alleviates intractable pain and…”
Get full text

Increased D 1 dopamine receptor signaling in levodopa‐induced dyskinesia by Aubert, Incarnation, Guigoni, Céline, Håkansson, Kerstin, Li, Qin, Dovero, Sandra, Barthe, Nicole, Bioulac, Bernard H., Gross, Christian E., Fisone, Gilberto, Bloch, Bertrand, Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa therapy for Parkinson's disease. Although changes affecting D 1 and D 2…”
Get full text

Striatal Overexpression of JunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease by Berton, Olivier, Guigoni, Celine, Li, Qin, Bioulac, Bernard H, Aubert, Incarnation, Gross, Christian E, DiLeone, Ralph J, Nestler, Eric J, Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of dopamine replacement therapy for Parkinson disease (PD). The transcription…”
Get full text

SHORT COMMUNICATION: Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning by Guigoni, Celine, Dovero, Sandra, Aubert, Incarnation, Li, Qin, Bioulac, Bernard H, Bloch, Bertrand, Gurevich, Eugenia V, Gross, Christian E, Bezard, Erwan

“…The extent of nigrostriatal denervation is presumed to play a role in the genesis of levodopa-induced dyskinesia. Yet some parkinsonian patients who have been…”
Get full text

Increased D sub(1) dopamine receptor signaling in levodopa-induced dyskinesia by Aubert, Incarnation, Guigoni, Celine, Haakansson, Kerstin, Li, Qin, Dovero, Sandra, Barthe, Nicole, Bioulac, Bernard H, Gross, Christian E, Fisone, Gilberto, Bloch, Bertrand, Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa therapy for Parkinson's disease. Although changes affecting D sub(1)…”
Get full text

Partial bilateral mesencephalic lesions affect D 1 but not D 2 binding in both the striatum and cortex by Pioli, Elsa, Sohr, Reinhard, Meissner, Wassilios, Barthe, Nicole, Gross, Christian E., Bezard, Erwan, Bioulac, Bernard H.

“…The substantia nigra pars compacta (SNc) and the ventral tegmental area (VTA) are the two major mesencephalic dopaminergic systems. Mesencephalic dopamine…”
Get full text

Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease by Berton, Olivier, Guigoni, Céline, Li, Qin, Bioulac, Bernard H, Aubert, Incarnation, Gross, Christian E, Dileone, Ralph J, Nestler, Eric J, Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of dopamine replacement therapy for Parkinson disease (PD). The transcription…”
Get full text